Exactech Expands Competency in 3-D Printing with Purchase of Arcam Q10plus Systems

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, has confirmed the purchase of two Arcam Q10plus machines this week to expand its in-house manufacturing capabilities. This investment will advance Exactech’s long-term commitment to additive manufacturing technology, also known as 3-D printing.

Advertisement

“Integrating the Arcam Q10plus technology into our operations will bring numerous benefits to our already robust manufacturing systems,” said Raymond Cloutier, Exactech vice president of engineering & development for spine. “In 2010, Exactech became the first company to receive FDA clearance for a 3-D printed orthopaedic implant and has since received multiple additional clearances for other implants. We will now be able to leverage this knowledge and experience to enhance the design of our hip, knee, extremities and spine implants, reduce product development lead times and further supplement supply.”

The Arcam Q10plus is Arcam’s latest Electron Beam Melting (EBM) machine that has been designed specifically for cost-efficient production of orthopaedic implants. Studies have shown that build times can be reduced up to 25 percent with improved surface finishes, compared to previous generations of EBM systems.¹

“Exactech was the first company in the U.S. to mass-produce medical implants using additive manufacturing. We are happy to see their confidence in our EBM technology and in the Arcam Q10plus as a volume production system for the medical device industry. We truly look forward to partnering with Exactech to grow production of their joint restoration products,” said Arcam Chief Executive Officer Magnus René.

“This equipment supports our long-range commitment to additive manufacturing, our comprehensive effort to optimize our supply chain and our perpetual interest in cost reduction,” said Exactech Chief Financial Officer Jody Phillips.

¹Data on file at Arcam.

About Exactech

Exactech develops and produces bone and joint restoration products that help surgeons worldwide make patients more mobile. With global headquarters in Gainesville, Fla., Exactech manufactures innovative solutions that improve patient outcomes for hip, knee, shoulder and spine surgery and distributes in more than 30 markets, including in the U.S., Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.